Malantide is a synthetic peptide phosphorylated by PKA and is used to measure PKA activity in vitro.

Dibutyryl-cAMP inhibits neuronal glucose uptake via PKA activation.

Afuresertib is a potent, orally bioavailable Akt inhibitor with Ki of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively.

Afuresertib HCl is a potent pan-Akt inhibitor with Ki values of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively.

GSK180736A is an inhibitor of G protein-coupled receptor kinase 2 (GRK2) with IC50 of 0.77 μM.

ML367 is a probe molecular that inhibits ATAD5 stabilization with an IC50 value of 1.2μM.

H 89 2HCl is a potent and selective inhibitor of cyclic AMP-dependent protein kinase (protein kinase A) with IC50 of 48 nM. It also shows weak inhibition on PKG, PKC, CK1, CK2 and others kinases.

8-Bromo-cAMP is a cell permeable analog of cAMP that activates cyclic-AMP-dependent protein kinase with a Ka value of 0.05 μM and a PKA activator.

STAD 2 is a PKA-tageting hydrocarbon stapled peptides. It is derived from the A Kinase Binding (AKB) domain of several AKAPs and was chemically modified to contain an all-hydrocarbon staple. Thus, it selectively binds PKA-RII and disrupt AKAP-mediated PKA signaling in cells.